CEACAM5 and colitis: They used carcinoembryonic antigen (CEA), which is overexpressed in colitis, as the target of CAR⁃Treg targeting, and designed a chimeric embryonic antigen receptor-regulated T cell (CEA-CAR⁃Treg) to target the inflammatory part of the colon.